DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Thuluvath PJ, Maheshwari A, Wong F. et al.
Oral V2 receptor antagonist (RWJ-351647) in patients with cirrhosis and ascites: a randomized, double-blind, placebo-controlled, single ascending dose study
Aliment Pharmacol Ther 2006; 24: 973-982
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.